Literature DB >> 16133558

Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.

Andreas Eisenhardt1, Winfried Siffert, Dieter Rosskopf, Michael Musch, Max Mosters, Ulla Roggenbuck, Karl-Heinz Jöckel, Herbert Rübben, Gerd Lümmen.   

Abstract

The T-allele in the GNB3 C825T polymorphism has been associated with increased cell migration, a prerequisite for metastasis. In this study we investigated a potential association of the C825T-allele status and disease progression in patients with transitional cell carcinoma of the bladder (TCC). Genotyping of the GNB3 C825T polymorphism was performed in 389 patients with transitional cell carcinoma of the bladder and in 104 control subjects and clinical follow-up was worked up in 339 patients. Genotype distribution in 389 patients with bladder cancer was comparable to genotype distribution of the control group. There was no association of GNB3 C825T genotype with tumor stage or grade, but follow-up analysis in the subgroup of non-smokers revealed a shorter time to metastasis in 825T-allele carriers compared to individuals homozygous CC. The genotype of the GNB3 C825T polymorphism appears to influence the biological behavior of tumor disease in non-smoking TCC patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133558     DOI: 10.1007/s00345-005-0006-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  25 in total

Review 1.  The genetics of transitional cell carcinoma: progress and potential clinical application.

Authors:  M A Knowles
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

2.  Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins.

Authors:  Dieter Rosskopf; Karin Koch; Christiane Habich; Jörg Geerdes; Axel Ludwig; Sabine Wilhelms; Karl H Jakobs; Winfried Siffert
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

Review 3.  A systematic overview of chemotherapy effects in urothelial bladder cancer.

Authors:  S Nilsson; P Ragnhammar; B Glimelius; P Nygren
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

4.  Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.

Authors:  C Heeschen; J J Jang; M Weis; A Pathak; S Kaji; R S Hu; P S Tsao; F L Johnson; J P Cooke
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

5.  Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs.

Authors:  E R Neptune; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.

Authors:  V B Thøgersen; B S Sørensen; S S Poulsen; T F Orntoft; H Wolf; E Nexo
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8.

Authors:  S Virchow; N Ansorge; D Rosskopf; H Rübben; W Siffert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-07       Impact factor: 3.000

Review 8.  Biological markers in superficial bladder tumors and their prognostic significance.

Authors:  A R Zlotta; C C Schulman
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

9.  Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

Authors:  M P Raitanen; P Nieminen; T L Tammela
Journal:  Br J Urol       Date:  1995-10

10.  Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele.

Authors:  S Virchow; N Ansorge; H Rübben; G Siffert; W Siffert
Journal:  FEBS Lett       Date:  1998-10-02       Impact factor: 4.124

View more
  7 in total

1.  [Genotype of the GNB3 C825T polymorphism, A risk factor for the development and course of prostate cancer?].

Authors:  A Eisenhardt; A Scherag; M Kempin; K H Jöckel; H Rübben
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme.

Authors:  Nicolai El Hindy; Michael Adamzik; Nicole Lambertz; Hagen S Bachmann; Karl Worm; Rupert Egensperger; Ulrich H Frey; Siamak Asgari; Ulrich Sure; Winfried Siffert; I Erol Sandalcioglu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-10       Impact factor: 4.553

3.  Novel somatic mutations in heterotrimeric G proteins in melanoma.

Authors:  L Isabel Cárdenas-Navia; Pedro Cruz; Jimmy C Lin; Steven A Rosenberg; Yardena Samuels
Journal:  Cancer Biol Ther       Date:  2010-07-01       Impact factor: 4.742

Review 4.  Subtype-dependent regulation of Gβγ signalling.

Authors:  Mithila Tennakoon; Kanishka Senarath; Dinesh Kankanamge; Kasun Ratnayake; Dhanushan Wijayaratna; Koshala Olupothage; Sithurandi Ubeysinghe; Kimberly Martins-Cannavino; Terence E Hébert; Ajith Karunarathne
Journal:  Cell Signal       Date:  2021-02-11       Impact factor: 4.850

5.  Comparative analysis of protein-protein interactions in cancer-associated genes.

Authors:  Purnima Guda; Sridar V Chittur; Chittibabu Guda
Journal:  Genomics Proteomics Bioinformatics       Date:  2009-06       Impact factor: 7.691

6.  Estimation of the relationship between the polymorphisms of selected genes: ACE, AGTR1, TGFβ1 and GNB3 with the occurrence of primary vesicoureteral reflux.

Authors:  Marcin Życzkowski; Joanna Żywiec; Krzysztof Nowakowski; Andrzej Paradysz; Władyslaw Grzeszczak; Janusz Gumprecht
Journal:  Int Urol Nephrol       Date:  2016-12-17       Impact factor: 2.370

Review 7.  Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.

Authors:  Nadezda Lipunova; Anke Wesselius; Kar K Cheng; Frederik J van Schooten; Jean-Baptiste Cazier; Richard T Bryan; Maurice P Zeegers
Journal:  Biomark Cancer       Date:  2019-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.